As a leading provider of Patient Monitoring Devices driven by R&D and intelligent manufacturing, SCIAN｜HONSUN (920278) focuses on blood pressure monitoring, nebulization therapy, home care, and clinical diagnostics. The company holds international certifications including CE, FDA, and ISO13485. To date, it has been granted 113 patents (including 9 invention patents), with products exported to more than 110 countries and regions worldwide.
Since 1993, we have been a high-tech enterprise specializing in independent R&D, manufacturing, and sales. Our headquarters is located in Shanghai, China, and our production base is in Nantong, Jiangsu. Our Patient Monitoring Devices portfolio includes aneroid sphygmomanometers, stethoscopes, nebulizers, electronic blood pressure monitors, oral irrigators, nasal irrigators, thermometers, body composition analyzers, oxygen concentrators, and negative pressure wound therapy devices.
Patient Monitoring Devices Export Volume has Ranked First Globally for Seven Consecutive Years.
7 International Quality Certifications (SAHH, CE, FDA, ISO13485, etc.), 113 Authorized Patents, and Service in 120 Countries.
Medical-Grade Standards, Suitable for both Clinical and Home Use.
Independently Developed with Customizable Options to Meet Client Requirements.
English
